𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection

✍ Scribed by U. B. Schaad; A. Gianella-Borradori; B. Perret; P. Imbach; A. Morell

Publisher
Springer
Year
1988
Tongue
English
Weight
374 KB
Volume
147
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

✦ Synopsis

Seven paediatric patients with symptomatic human immunodeficiency virus (HIV) infection were prospectively studied for 6-24 months after the start of intravenous immune globulin (IVIG) therapy. There was substantial clinical benefit during IVIG treatment with marked reduction of febrile and infectious episodes, normalization of physical and psychomotor development, and absence of mortality. The immunologic monitoring revealed some discrete objective improvements. The results of this study favourably compare to previous reports. It is concluded that IVIG should be standard therapy for symptomatic childhood HIV infection.

πŸ“œ SIMILAR VOLUMES

Elevated levels of circulating immune co
Elevated levels of circulating immune complexes in human immunodeficiency virus infection
✍ Mohan M. Reddy; Michael H. Grieco πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 316 KB

Circulating immune complexes were quantitated in asymptomatic intravenous drug abusers (IVDA), male homosexuals, and patients with lymphadenopathy or acquired immunodeficiency syndrome (AIDS) by two different methods. Circulating immune coinplexes were elevated in HIV-seronegative

Autoantibodies and circulating immune co
Autoantibodies and circulating immune complexes in subjects infected with human immunodeficiency virus
✍ Rosemary Mayer-Siuta; Lynn B. Keil; Vincent A. DeBari πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 490 KB

We wish to report the results of a retrospective study of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC) as well as a group of asymptomatic human immunodeficiency virus (HIV)-infected individuals, in whom we examined markers of systemic autoimmune disease incl